本頁面由Tiger Trade Technology Pte. Ltd.提供服務

10x Genomics, Inc.

18.39
+0.01000.05%
盤後18.430.0400+0.22%17:28 EDT
成交量:234.61萬
成交額:4,304.03萬
市值:23.48億
市盈率:-52.69
高:18.65
開:18.42
低:18.09
收:18.38
52周最高:23.56
52周最低:6.78
股本:1.28億
流通股本:1.15億
量比:0.84
換手率:2.04%
股息:- -
股息率:- -
每股收益(TTM):-0.3490
每股收益(LYR):-0.3490
淨資產收益率:-5.78%
總資產收益率:-6.40%
市淨率:2.95
市盈率(LYR):-52.69

資料載入中...

2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

重要事件披露

Form 8-K - Current report
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/07

重要事件披露

Form 8-K - Current report
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report